Trading Profile: Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitors multiple blood measurements, including carboxyhemoglobin, methemoglobin, pleth variability index, total hemoglobin, acoustic respiration rate, and Halo Index. It develops, manufactures, and markets a family of patient monitoring solutions, which incorporate a monitor or circuit board and sensors comprising proprietary single-patient use and reusable sensors, and cables. The company also offers patient SafetyNet, a remote monitoring and clinician notification system, and software. It sells its products to end users hospitals and the emergency medical response organizations through its direct sales force and distributors, as well as to original equipment manufacturer partners. The company was founded in 1989 and is headquartered in Irvine, California.
»»» Detailed Company Profile & Chart
Masimo Corp current day financials: 2024-04-25 05:20:05amSymbol | Name | Purchase price | Last Price | Change | % Change |
---|---|---|---|---|---|
0.00 | |||||
Recent MASI News from Yahoo Finance & Seeking Alpha
Masimo to Report First Quarter 2024 Financial Results after Market Close on Tuesday, May 7 »
IRVINE, Calif., April 23, 2024--Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? »
Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Reasons Why You Should Retain Masimo (MASI) Stock for Now »
Masimo's (MASI) R&D activities raise optimism about the stock.
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally? »
Masimo's (MASI) shares have risen year to date on the back of strong fundamentals. However, rising costs can be a cause of concern.
Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile »
SANTIAGO, Chile, April 16, 2024--Masimo CEO Joe Kiani will speak at the Global Ministerial Summit on Patient Safety in Chile about how AI-based solutions can improve patient safety.
Older Archived News Masimo Corp
- Why This CEO Was Offered $147 Million to Give Up Benefits.
- Masimo CEO Kiani Awarded $119 Million, Surrenders Some Benefits.
- Today's Strong And Under The Radar Stock: Masimo (MASI).
- T.J. Samson is the First Hospital in Kentucky to Adopt Patient SafetyNetâ„¢.
- Masimo to Present at 33rd Annual J.P. Morgan Healthcare Conference.
- Masimo to Present at 27th Annual Piper Jaffray Healthcare Conference.
- Masimo SET Technology Picked by India's Cloudnine Hospital.
- Masimo Receives 2014 Zenith Award at the American Association of Respiratory Care Congress.
- Masimo Corp. Earnings Q3, 2015.
- Masimo Corp. breached its 50 day moving average in a Bearish Manner : December 4, 2015.Load More News...